Profit-taking hits gold

Gold is trading at $1333, down 0.5% as profit-taking sets in after the precious metal hit a three-week high yesterday.

The US non-farm payrolls report, which came in below analysts’ estimates, gave an indication to the market that the US Federal Reserve will not reduce its $85 billion per month bond-buying programme until the first quarter of 2014.

While the Fed keeps its stimulus package in place the US dollar will remain under pressure, making it relatively cheaper to buy gold. Gold reached its highest level yesterday since the end of September, and today, though we have seen some sellers,  the price is still well above the pre non-farm payrolls level of $1320.

Overnight, the Industrial & Commercial Bank of China reported a large increase in the number of bad debts, which worried investors as it’s not the first time there have been concerns over the Chinese banking system. If other banks in China start to report defaults on loans we could see investors take their cash out of equities and invest in gold.

Spot Gold (DFB) chart

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.